ANTIBIOTIKLARGA CHIDAMLILIKNING SOG'LIQNI SAQLASH NATIJALARIGA TA'SIRI

Maqola yon paneli

PDF (inglizcha)
Nashr qilingan: 2024-11-23
DOI: https://doi.org/10.66073/researchfocus.v3i10.1114
Kalit so‘zlar:
Antibiotiklarga chidamlilik, sog'liqni saqlash natijalari, antimikrob preparatlarni oqilona qo'llash dasturlari, kasalxonada yotish muddati, davolash xarajatlari, o'lim ko'rsatkichlari, infeksiya asoratlari, jamoat salomatligi

Maqolaning asosiy mazmuni

Imran Aslam
Ilmiy assistent va assistent, Farmakologiya kafedrasi, Samarqand davlat tibbiyot universiteti
Ayesha Ashraf
Assistent, Jamoat salomatligi kafedrasi, Samarqand davlat tibbiyot universiteti

Abstrak

Antibiotiklarga chidamlilik (ABR) zamonaviy sog'liqni saqlash tizimida jiddiy muammo sifatida yuzaga chiqdi va bemorlarni davolash natijalariga, sog'liqni saqlash tizimlariga hamda jahon jamoat salomatligiga sezilarli ta'sir ko'rsatmoqda. Bakteriyalar keng qo'llaniladigan antibiotiklarga chidamlilik hosil qilgani sari infeksiyalarni davolash tobora murakkablashib bormoqda, bu esa gospitalizatsiya muddatining uzayishiga, davolash xarajatlarining ortishiga hamda kasallanish va o'lim ko'rsatkichlarining oshishiga olib keladi. Ushbu tadqiqotda ABRning davolash natijalariga ta'siri, u keltirib chiqaradigan klinik, iqtisodiy va tizimli qiyinchiliklarni qamrab olgan holda o'rganiladi. Maqolada bu oqibatlarni yumshatishda antimikrob preparatlardan oqilona foydalanish dasturlarining ahamiyati ta'kidlanadi va mavjud shifoxona siyosati hamda tartib-qoidalarini takomillashtirish bo'yicha tavsiyalar beriladi.

Maqola tafsilotlari

Nashr

Jild 3 Nomeri 10 (2024): Research Focus International Scientific Journal. 3-tom, 10-son (2024)

Bo'lim

14.00.00 – Tibbiyot fanlari
Creative Commons litsenziyasi

Ushbu asar Creative Commons Attribution 4.0 International litsenziyasi asosida litsenziyalangan.

Qanday iqtibos keltirish kerak

ANTIBIOTIKLARGA CHIDAMLILIKNING SOG’LIQNI SAQLASH NATIJALARIGA TA’SIRI. (2024). Research Focus International Scientific Journal, 3(10), 131-138. https://doi.org/10.66073/researchfocus.v3i10.1114

Adabiyotlar

Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J.,

... & Trivedi, K. K. (2016). Implementing an antibiotic stewardship program: Guidelines by the

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of

America. Clinical Infectious Diseases, 62(10), e51-e77.

Baxter, C. G., Russell, C., Duncan, H., Farrell, S., Law, S., Baker, J., & Denning, D. W. (2016).

Clinical and laboratory features of invasive aspergillosis and the significance of aspergillus in

respiratory samples in acute leukaemia and haematopoietic stem cell transplantation. British

Journal of Haematology, 139(3), 504-515.

Centers for Disease Control and Prevention (2019). Antibiotic resistance threats in the United

States. Retrieved from https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threatsreport-508.pdf

Cosgrove, S. E., & Carmeli, Y. (2003). The impact of antimicrobial resistance on health and

economic outcomes. Clinical Infectious Diseases, 36(11), 1433-1437.

Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., ...

& Hooton, T. M. (2007). Infectious Diseases Society of America and the Society for Healthcare

Epidemiology of America guidelines for developing an institutional program to enhance

antimicrobial stewardship. Clinical Infectious Diseases, 44(2), 159-177.

Dyar, O. J., Huttner, B., Schouten, J., & Pulcini, C. (2017). What is antimicrobial stewardship?

Clinical Microbiology and Infection, 23(11), 793-798.

Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., ... &

Piddock, L. J. V. (2016). Understanding the mechanisms and drivers of antimicrobial

resistance. The Lancet, 387(10014), 176-187.

Aslam, I., & Jiyanboyevich, Y. S. (2023). THE COMMON PROBLEM OF

INTERNATIONAL STUDENTS AND ITS SOLUTION AND UNEXPECTED

CHALLENGES OF WORKING WITH FOREIGN TEACHER. Internationalization of

Medical Education: Experience, Problems, Prospects, 66.

Jiyanboevich, Y. S., Aslam, I., & Soatboyevich, J. N. (2024). FAILURE OF THE HEART

DETERMINATION PROTEOMIC PROFILING RELATED TO PATIENTS WHO ARE

ELDERLY. Research Focus, 3(1), 198-203.

Nodirovna, A. R., Maksudovna, M. M., Aslam, I., & Ergashboevna, A. Z. (2024). Evaluating

Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and

Treatment. International Journal of Alternative and Contemporary Therapy, 2(5), 135-141.

Shahzoda, K., Aslam, I., Ashraf, A., Ergashboevna, A. Z., & Ergashboevna, E. M. (2024).

ADVANCEMENTS IN SURGICAL TECHNIQUES: A COMPREHENSIVE

REVIEW. Ta'limda raqamli texnologiyalarni tadbiq etishning zamonaviy tendensiyalari va

rivojlanish omillari, 31(2), 139-149.RESEARCH FOCUS | VOLUME 3 | ISSUE 10 | 2024

ISSN: 2181-3833 ResearchBip (12.32) | Google Scholar | Index Copernicus (ICV69.78)

Research Focus International Scientific Journal, Uzbekistan 138 https://refocus.uz/

Aslam, I., & Jiyanboyevich, Y. S. (2023). THE COMMON PROBLEM OF

INTERNATIONAL STUDENTS AND ITS SOLUTION AND UNEXPECTED

CHALLENGES OF WORKING WITH FOREIGN TEACHER. Internationalization of

Medical Education: Experience, Problems, Prospects, 66.

Nodirovna, A. R., Maksudovna, M. M., Aslam, I., & Ergashboevna, A. Z. (2024). Evaluating

Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and

Treatment. International Journal of Alternative and Contemporary Therapy, 2(5), 135-141.

Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood

Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and

Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889.

Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood

Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and

Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889.